Kamiya Biomedical Company (USA)

Today KAMIYA's product lines include over 1500 different preclinical testing products, human biomarker assays, enzyme inhibitors, enzyme substrates, monoclonal and polyclonal antibodies, and small molecules for research in apoptosis, multidrug resistance, oxidative / DNA damage and repair, bone biology, cancer, cardiac health, inflammation, stress, obesity, and diabetes.

KAMIYA now has the broadest product line of liquid serum protein immunoassay reagents of any company in the U.S., and supplies clinical diagnostic reagents to leading hospitals, medical centers, clinical laboratories, clinical reference labs, research facilities, distributors, and diagnostic instrument companies worldwide.